ScripScrip regularly covers business development and deal making in the biopharmaceutical industry. Deal Watch is supported by deal intelligence from Biomedtracker. Bristol, VantAI Pair Technologies In Pr
ScripDrug developers and investors left San Francisco after the recent J.P. Morgan Healthcare Conference feeling optimistic about prospects for returns on biopharmaceutical investments, certain that forthc
ScripErasca Inc. and Imago BioSciences, Inc. raised the most money out of the five biopharmaceutical companies that launched initial public offerings during the first half of July, and their stocks were